News

Hydreight Unveils Innovative Genetic Testing on VSDHOne Platform

Hydreight Unveils Innovative Genetic Testing on VSDHOne Platform

Hydreight Launches Revolutionary Genetic Testing Solution

Hydreight Technologies Inc. is a rapidly expanding digital health platform that delivers compliant mobile and telehealth services throughout the United States. With an exciting announcement, Hydreight has launched a new
genetic testing and personalized wellness solution on its VSDHOne platform, making waves in the health tech industry. This initiative allows consumers to access at-home DNA testing kits, followed by customized health plans specifically tailored to their unique genetic makeup.

Accessible Health Plans Tailored for You

The new genetic testing service enables easy access to DNA swab kits, allowing individuals to receive insights regarding their health, nutrition, fitness, and even medication compatibility. With a distinctly individualized approach, this service empowers users to optimize their health outcomes based on their genetic information. Once results are obtained, clients can continue their healthcare journey on the VSDHOne platform, connecting them with licensed providers who can offer personalized treatments, wellness protocols, and continuous support.

Key Features of the Genetic Testing Service

The offering includes several key features that enhance user experience and health management:

  • At-home DNA swab kits
  • Comprehensive lab-based genetic analysis
  • Tailored health and wellness recommendations
  • Consultation with licensed genetic experts
  • Customized guidance on supplements and medication influenced by genetic markers
  • Home delivery and nationwide fulfillment

Enhancing Preventive Health Care Across the Nation

This move by Hydreight comes at a time when 70% of chronic diseases are attributed to lifestyle and environmental factors. By integrating genetic insights, Hydreight’s personalized wellness plans promote a proactive approach to healthcare that allows for earlier intervention and better health outcomes. Increased access to this information empowers consumers to make informed decisions about their health and wellness.

Market Potential and Future Growth

The global consumer genomics market is on track to surpass $50 billion, driven by the growing demand for personalized medicine and health optimization strategies. With the at-home testing market projected to exceed $15 billion, Hydreight stands to make a significant impact by directly offering genetic testing and personalized regimens to clients, all without the constraints of traditional lab infrastructures.

Subscription-Based Revenue Model for Sustainable Growth

Hydreight's new offering is designed around a subscription model, generating initial revenue from testing kits along with recurring monthly income from continuous tailored health regimens and supplement deliveries. This integration into the VSDHOne platform allows direct-to-consumer (D2C) brands and healthcare professionals to offer genetic testing services seamlessly, enhancing customer retention and increasing lifetime value.

Strategic Priorities for 2025

Hydreight is set to leverage its genetic testing initiative to expand high-margin white-label services, onboard licensed D2C brands, and explore new wellness categories, including testosterone replacement therapy and longevity protocols. By continually enhancing its infrastructure and offerings, Hydreight is constructing one of the largest and most effective mobile clinic networks in the U.S., ensuring accessible healthcare for all.

A Vision for the Future of Healthcare

As the healthcare landscape evolves, Hydreight is identifying itself as a revolutionary force in the sector. By embedding genetic testing within its comprehensive platform, Hydreight embodies the essence of modern healthcare — a streamlined, user-centric approach accessible to consumers everywhere. Shane Madden, CEO of Hydreight Technologies, articulated this vision, emphasizing that they are not just offering services but are transforming the care journey by empowering individuals.

Frequently Asked Questions

What is Hydreight Technologies Inc.?

Hydreight is a digital health platform facilitating mobile and telehealth services across the U.S., focusing on personalized wellness solutions.

What services does the VSDHOne platform offer?

The VSDHOne platform provides genetic testing, personalized health plans, telehealth consultations, and wellness support.

How does the genetic testing work?

Consumers can order at-home DNA swab kits, which are then analyzed to provide insights into their health, nutrition, and potential medication compatibility.

What is the subscription model in Hydreight's wellness offerings?

Hydreight's offerings include an initial fee for testing kits and ongoing monthly fees for tailored wellness regimens and supplement deliveries.

What are the company’s future growth plans?

Hydreight aims to expand its D2C services, onboard new brand partners, and explore innovative wellness categories for better health management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading